样式: 排序: IF: - GO 导出 标记为已读
-
Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-12 Masanori Kato, Hidetoshi Ito, Akane Yamakawa, Tatsuo Kagimura, Masafumi Fukagawa, Masahiro Yamamoto, Yoshinori Saito, Tadao Akizawa, Hiroaki Ogata
The clinical benefits of aspirin in patients undergoing hemodialysis remain unclear.
-
Successful treatment with granulocyte and monocyte adsorption apheresis for plaque‐type skin lesions in patients with psoriatic arthritis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-13 Mariko Seishima, Hideki Hachiken, Takuma Furukawa, Junichiro Yamamoto
IntroductionGranulocyte and monocyte adsorption apheresis (GMA) is usually performed weekly for refractory skin diseases, such as generalized pustular psoriasis and psoriatic arthritis (PsA).MethodsFour patients with PsA who were refractory to previous treatments were enrolled. They received five or ten sessions of GMA. We assessed the clinical conditions of each patient and laboratory findings before
-
A global assessment of hemostatic function of healthy allogeneic stem cell donors undergoing apheresis by rotational thromboelastometry Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-11 Neslihan Cilek, Elif Ugurel, Ozgur Can Eren, Ozlem Yalcin, Olga Meltem Akay
IntroductionPeripheral blood stem cell (PBSC) collection via apheresis requires the administration of granulocyte colony‐stimulating factor (filgrastim) to stem cell donors. Several reports have shown that filgrastim administration and apheresis procedure induce a hypercoagulable state across PBSC collection, which might predispose certain donors to thrombotic complications.MethodsWe evaluated the
-
Associations of vitamin D receptor activators and calcimimetics with falls and effect modifications by physical activity: A prospective cohort study on the Japan Dialysis Outcomes and Practice Patterns Study Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-11 Miho Murashima, Ryohei Yamamoto, Eiichiro Kanda, Noriaki Kurita, Hisashi Noma, Takayuki Hamano, Masafumi Fukagawa
IntroductionThis study aimed to examine the associations of vitamin D receptor activators (VDRA) and calcimimetics use with falls.MethodsThis is a prospective cohort study on hemodialysis patients in the Japan Dialysis Outcomes and Practice Patterns Study. We excluded those who were unable to walk. The associations of VDRA or calcimimetics use with falls and effect modifications by physical activity
-
Investigation of treatment volume versus circulating blood volume during Rheocarna treatment Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-08 Yuki Hoshikawa, Atsushi Ohkubo, Takatoshi Sakurasawa, Mana Usui, Masaya Deushi, Hiroko Yamamoto, Shotaro Naito
IntroductionRheocarna's therapeutic effect is associated with fibrinogen (Fib) and low‐density lipoprotein cholesterol (LDL‐C) adsorptive removal. This study aimed to retrospectively investigate the association between treatment volume (TV) and circulating blood volume (CBV) and the Fib removal rate (Fib‐RR) and LDL‐C‐RR.MethodsCBV and TV/CBV, cut‐off value (CO value), and area under the receiver operating
-
The 44th Annual Meeting of the Japanese Society for Apheresis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-08 Takaya Abe
-
A retrospective study describing the effective exchange of total blood plasma for disease control in the exacerbation of serpiginous choroiditis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-07 Yuri Katayama, Daisuke Katagiri, Takuya Harada, Kanako Terakawa, Keiki Shimada, Emi Sakamoto, Takahito Niikura, Minami Suzuki, Yuki Yoshizaki, Naoto Nunose, Motohiko Sato, Shigeko Yashiro, Hiroshi Kaneko, Hideki Takano
IntroductionSerpiginous choroiditis presents with large yellow‐white exudative lesions that occur near the optic nerve papillae, that progresses slowly with repeated relapses and cures. Although infection and autoimmunity have been implicated, the cause is unknown.MethodsA man was diagnosed with serpiginous choroiditis on clinical and other examinations. He started treatment with oral corticosteroids
-
Development and validation of a nomogram model for accurately predicting severe fatigue in maintenance hemodialysis patients: A multicenter cross‐sectional study in China Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-06 Xinyuan Zhou, Jiahui Han, Fuxiang Zhu
IntroductionThis study aims to analyze the risk factors for severe fatigue in maintenance hemodialysis (MHD) patients and develop a clinical prediction model to help doctors and patients prevent severe fatigue.MethodsMulticentre MHD patients were included in this study. The objective was to investigate the risk factors for severe fatigue in MHD patients and develop a prediction model.ResultsA total
-
-
Therapeutic Apheresis and Dialysis Forthcoming Events April 2024 Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-03-04
-
-
Utilizing triple tandem extracorporeal membrane oxygenation, therapeutic plasma exchange, and continuous renal replacement therapy in a neonate with elevated plasma‐free hemoglobin Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-02-27 Senan Hadid, Jay S. Raval
-
Changes in antibody titer after four and five doses of the SARS‐CoV‐2 vaccine in Japanese post‐kidney transplant patients Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-02-22 Kumiko Fujieda, Akihito Tanaka, Ryosuke Kikuchi, Nami Takai, Shoji Saito, Yoshinari Yasuda, Yuta Sano, Masashi Kato, Kazuhiro Furuhashi, Shoichi Maruyama
IntroductionImmunosuppressed patients exhibit low antibody acquisition rates following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination. Kidney transplant recipients previously exhibited low antibody acquisition rates after two vaccine doses, which increased after the third dose. We evaluated antibody titers of Japanese post‐kidney transplant patients after the fourth and fifth
-
Blood at the end of tunnel‐rare complication of tunneled cuff catheter Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-02-19 Asheesh Kumar, Samriti Gupta, Naresh Chauhan
-
Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330-II hemoperfusion Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-02-05 Juan Zhou, Haopeng Li, Lei Zhang, Guangjian Chen, Gang Wang, HuiHui Zhu, Yingxin Hao, Gang Wu
To explore the effect of CRRT using CVVHDF + HP on the removal of inflammatory mediators in patients with septic shock complicated with AKI.
-
Effectiveness and safety of plasma exchange for anti-MDA5 antibody–positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease refractory to intensive immune suppression therapy: A case series Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-01-15 Tomoka Watanabe, Misaki Taniguchi, Sanae Ogura, Mea Asou, Shunsuke Takayanagi, Yuko Sokai, Yoshiki Tsuji, Keita P. Mori, Tomomi Endo, Toshiki Nakajima, Yoshitaka Imura, Tatsuo Tsukamoto
Clinically amyopathic dermatomyositis (CADM) with anti-melanoma differentiation-associated gene 5 (MDA5) antibody (Ab) with rapidly progressive interstitial lung disease (RP-ILD) is often refractory for intensive immunosuppression. In this study, we verified the effectiveness and safety of plasma exchange (PEx) for this lethal disease.
-
The efficacy and safety of ivabradine hydrochloride in hemodialysis patients with chronic heart failure Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-01-10 Sayuri Kawasaki, Yukinao Sakai, Shinsuke Harasawa, Akihito Inatsu, Yoshiaki Kubota, Akio Hirama, Tetsuya Kashiwagi, Masato Iwabu
There is little evidence for ivabradine hydrochloride in patients undergoing hemodialysis.
-
Correlation between bradykinin concentration and blood pressure during Rheocarna therapy: A single-center case series Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-01-03 Takaya Handa, Masaki Fujii, Masumi Ando, Mayumi Masuda, Yuko Sokai, Yoshiki Tsuji, Yui Fukuda, Kaoru Ohue, Yoshiaki Higashi, Keita P. Mori, Tomomi Endo, Tatsuo Tsukamoto
A novel LDL (low-density lipoprotein) apheresis therapeutic option, Rheocarna, has garnered attention as an alternative therapy for chronic limb-threating ischemia (CLTI). Bradykinin-mediated vasodilation is involved in the effects of LDL apheresis and a decrease in blood pressure (BP), but the changes in bradykinin concentration during Rheocarna therapy are unknown.
-
The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-01-02 Nobuhiro Ueno, Seisuke Saito, Masahiro Sato, Yuya Sugiyama, Yu Kobayashi, Yuki Murakami, Kohjiro Sugimura, Takahiro Sasaki, Aki Sakatani, Keitaro Takahashi, Kazuyuki Tanaka, Shinya Serikawa, Katsuyoshi Ando, Shin Kashima, Momotaro Muto, Yuhei Inaba, Kentaro Moriichi, Hiroki Tanabe, Toshikatsu Okumura, Mikihiro Fujiya
A remission induction therapy of granulocyte and monocyte adsorptive apheresis (GMA) was given to patients with Crohn's disease (CD). However, establishing an appropriate treatment strategy for GMA in patients with CD remains unclear.
-
Using the concept of food as medicine to mitigate inflammation in patients undergoing peritoneal dialysis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-01-01 Livia Alvarenga, Drielly C. M. V. Reis, Julie Ann Kemp, Karla Thais Resende Teixeira, Denis Fouque, Denise Mafra
The most common kidney replacement therapy (KRT) worldwide is hemodialysis (HD), and only 5%–10% of patients are prescribed peritoneal dialysis (PD) as KRT. Despite PD being a different method, these patients also present particular complications, such as oxidative stress, gut dysbiosis, premature aging, and mitochondrial dysfunction, leading to an inflammation process and high cardiovascular mortality
-
Health literacy in older adults receiving hemodialysis in Turkey: A cross-sectional study Ther. Apheresis Dial. (IF 1.9) Pub Date : 2024-01-01 Ziyafet Uğurlu, Sultan Kav, Çiğdem Özdemir Eler, Semiha Kaya, Yasemin Korkmaz
This study aimed to determine the health literacy level and related factors of older adults receiving hemodialysis treatment.
-
Peritoneal dialysis in Herzegovina, Federation of Bosnia and Herzegovina: 18 years of experience from our center Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-12-20 Fila Raguž, Monika Tomić, Andrea Stojčić, Manuel Tipurić, Mile Volarić, Sanja Bevanda
Due to treatment of end-stage-renal-disease (ESRD), continuous peritoneal dialysis (CAPD) is used in 11% of cases and is associated with several PD-associated infections.
-
Red cell distribution width to albumin ratio predicts treatment failure in peritoneal dialysis-associated peritonitis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-12-19 Yujian He, Fei Xiao, Qingyun Luo, Jinlan Liao, Huie Huang, Yan He, Min Gao, Yumei Liao, Zibo Xiong
This study aims to investigate the potential correlation between baseline red cell distribution width (RDW) to albumin ratio (RAR) levels and treatment failure in peritoneal dialysis-associated peritonitis (PDAP) patients.
-
Therapeutic plasma exchange for refractory Kawasaki disease in children weighing less than 10 kg Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-12-14 Mariko Sawada, Kayo Ogino, Tomohiro Hayashi, Kenji Waki
Therapeutic plasma exchange (TPE) is used for treating refractory Kawasaki disease (KD); however, there are few reports on its use in small children.
-
Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-12-12 Kie Sekiguchi, Takaya Abe, Ei Shiomi, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takashi Sekiguchi, Wataru Obara
We aimed to determine whether unfractionated heparin (UH) and low molecular weight heparin (LH) contribute to aberrant carnitine metabolism in patients receiving hemodialysis.
-
Association between hyponatremia, inflammation, and mortality in patients undergoing peritoneal dialysis: A nationwide observations Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-12-14 Bulent Erdogan, Naim Ata, Murat Caglayan, Melih Gaffar Gözükara, Emin Gemcioglu, Fevzi Coskun Sokmen, Nuray Yilmaz, Osman Celik, Mustafa Okan Ayvali, Mustafa Mahir Ulgu, Suayip Birinci
Hyponatremia is the most common electrolyte disorder often present in peritoneal dialysis (PD) patients. The aim of this retrospective study was to investigate the effect of hyponatremia on mortality in patients undergoing PD.
-
Ultrasound findings of the sternoclavicular and shoulder joints in patients on maintenance hemodialysis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-12-12 Lin Zhai, Siyu Wang, Fei Xue, Ying Yao
Ultrasonographic examination of joints is a non-invasive method to detect and monitor Dialysis-associated amyloidosis (DRA).
-
Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-12-09 Kenichi Ito, Tomoki Kawasaki, Kazuhiko Hirano, Naohiro Sekiguchi
Hyperviscosity syndrome (HVS) is a significant complication in Waldenström's macroglobulinemia (WM), although the significance of plasmapheresis in clinical practice has not been clarified. To confirm the efficacy and safety of plasmapheresis followed by primary therapy for WM with HVS, we retrospectively conducted this study.
-
A 54-year-old man with gout-induced immobilization hypercalcemia. Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-27 Ning Lin,Yanshan Chen,Lingling Xu
-
Vascular calcification inhibitors and cardiovascular events in peritoneal dialysis patients Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-27 Refik Olmaz, Tamer Selen, Ozkan Gungor
The prevalence of cardiovascular diseases is high among patients with chronic kidney disease (CKD) and peritoneal dialysis (PD) patients, which increases morbidity and mortality in this population and represents a significant financial burden for both the patients and the healthcare systems. Vascular calcification (VC) is associated with increased morbidity and mortality and VC risk is higher in patients
-
Overlooked factor in the etiology of pruritus in hemodialysis patients: Ultrafiltration volume Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-22 Hakan Ozer, Yasin Ozturk, Fethi Yonet, Ismail Baloglu, Kultigin Turkmen, Nedim Yılmaz Selcuk, Halil Zeki Tonbul
This study investigated the relationship between ultrafiltration (UF) volume and pruritus severity based on the idea that skin perfusion and inflammatory changes occur in dialysis patients with high UF volume.
-
Predictive performance of the sequential organ failure assessment score for in-hospital mortality in patients with end-stage kidney disease in intensive care units: A multicenter registry in Japan Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-20 Hiroki Shimada, Yoshinori Matsuoka, Chisato Miyakoshi, Jiro Ito, Ryutaro Seo, Koichi Ariyoshi, Yosuke Yamamoto, Hiroyuki Mima
There is limited evidence regarding whether the performance of the Sequential Organ Failure Assessment (SOFA) score differs between patients with and without end-stage kidney disease (ESKD) in intensive care units (ICUs).
-
Evaluation of bone marrow findings in hemodialysis patients with erythropoietin-resistant anemia Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-20 Mehmet Yilmaz, Volkan Karakuş, Egemen Kaya, Nevruz İlhanlı, Bülent Huddam
Treatment with erythropoietin-stimulating agents (ESAs) is widely used in anemia of chronic kidney disease (CKD). Acquired ESA resistance is an important problem. The aim of this study is to examine the bone marrow findings in hemodialysis patients with ESA-resistant anemia.
-
Investigation of the reasons for patients who choose peritoneal dialysis as kidney replacement therapies to change their decisions Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-20 Murat Altunok, Erdem Çankaya, Can Sevinç, Abdullah Uyanık
Peritoneal dialysis (PD) is one of the kidney replacement therapies (KRT). Patients' choice of KRT is influenced by personal causes, familial factors, factors related to healthcare professionals, and social factors.
-
A pilot study of intensive short-time continuous renal replacement therapy to substitute maintenance hemodialysis during transitional period of COVID-19 Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-15 Jing Xu, Cheng Xue, Fangzheng Cui, Jiayi Lv, Yanqing Jie, Lingling Liu, Qianwen Zheng, Haigu Fang, Xiangdong Li, Bing Dai, Jing Chen, Zhiguo Mao
There is a lack of perfect solutions for maintenance hemodialysis (MHD) in patients with a high transmission risk of SARS-CoV-2.
-
Management of kidney injury in critically ill patients with earthquake-induced crush syndrome: A case series of 18 patients Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-14 Murat Aslan, Deniz Özel Bilgi
It was aimed primarily to analyze the development of acute kidney injury (AKI) and treatment management in critically ill patients who developed rhabdomyolysis due to earthquake-related crush syndrome.
-
Successful treatment with anti-tuberculous drugs and zoledronate of hypercalcemia due to calcitriol overproduction in a patient undergoing maintenance dialysis complicated by tuberculous pleuritis. Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-11 Shunsuke Yamada,Takanari Kitazono,Toshiaki Nakano
-
A simple score for malnutrition–inflammation complex syndrome (MICS) is associated with the risk of mortality in Japanese patients undergoing maintenance hemodialysis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-09 Shunsuke Yamada, Hokuto Arase, Masatomo Taniguchi, Takanari Kitazono, Toshiaki Nakano
Malnutrition–inflammation complex syndrome (MICS) is highly prevalent in patients undergoing hemodialysis. We determined the prognostic value of the Simple MICS score, calculated using a combination of age, body mass index, and serum concentrations of albumin, creatinine, and C-reactive protein.
-
Two successful pregnancies in a woman with Fabry continuing enzyme replacement therapy. Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-08 Saime Paydas,Cigdem Akcabay
-
The effect evaluation of continuous nursing intervention in patients with type 2 diabetic retinopathy Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-08 Hui Du, Jian-Bo Xiao, Jing Li
To evaluate the application effect of continuous nursing intervention in type 2 diabetic retinopathy (DR).
-
The effect of hand fine motor skills on peritoneal dialysis-related peritonitis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-06 Ibrahim Dogan, Emel Ucar, Mehtap Odabas, Nur Unal Kaya, Rezzan Eren Sadioglu, Gulden Celik, Elif Acikgoz, Hayriye Sayarlioglu, Ercan Turkmen, Bulbul Delibalta, Nimet Aktas, Selma Kuran Cakir, Emel Acar Kaya, Serap Alsancak, Yavuz Ayar, Narin Ustunel, Zuhal Inan, Tolga Yildirim, Fatma Sen, Aysegul Oruc, Rahime Korkmaz, Huseyin Kayadibi, Kenan Ates
We aimed to evaluate the relationship between the hand fine motor skills of peritoneal dialysis (PD) practitioners and PD-related peritonitis.
-
Effect of renin–angiotensin system inhibitors on cardiovascular events in hemodialysis patients with hyperphosphatemia: A post hoc analysis of the LANDMARK trial Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-11-03 Yoshinori Saito, Hidetoshi Ito, Masafumi Fukagawa, Tadao Akizawa, Tatsuo Kagimura, Masahiro Yamamoto, Masanori Kato, Hiroaki Ogata
The clinical benefits of renin–angiotensin system inhibitors (RASi) in patients undergoing hemodialysis remain obscure.
-
Hospitalizations for non-SARS-CoV-2 respiratory infectious diseases among patients on hemodialysis: A comparison before and during the coronavirus disease 2019 pandemic Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-31 Masataka Banshodani, Hideki Kawanishi, Misaki Moriishi, Naoko Takahashi, Sadanori Shintaku, Shinichiro Tsuchiya
The impact of coronavirus disease 2019 (COVID-19) infection control on other infections in patients with dialysis has not received sufficient consideration.
-
The relationship between decline rate of residual renal function in the first year and mortality in peritoneal dialysis patients Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-24 Na Wu, Sijia Chen, Fenfen Peng, Congwei Luo, Peilin Li, Yihua Chen, Weidong Zhou, Haibo Long, Qixuan Yang
To assess the relationship between the rate of residual renal function (RRF) decline in the first year and all-cause and cardiovascular mortality in peritoneal dialysis (PD) patients.
-
Effect of intradialytic weight resistance training exercise in sarcopenic hemodialysis patients: A randomized controlled trial Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-24 Chokchai Chaovarin, Amnart Chaiprasert, Bancha Satirapoj, Naowanit Nata, Wisit Kaewput, Theerasak Tangwonglert, Narittaya Varothai, Paramat Thimachai, Pamila Tasanavipas, Pitchamon Inkong, Narongrit Siriwattanasit, Natthaya Khrongkab, Ouppatham Supasyndh
Sarcopenia has a high prevalence in end-stage kidney disease (ESKD). However, there is limited evidence of resistance exercise in these patients.
-
Effect of hospital-community online management on medication management of elderly patients with peritoneal dialysis during COVID-19 Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-24 Chi Zhang, Jun-Sheng Wang, Xiao-hui Xie
The study aimed to explore feasibility and effect of hospital-community online management on the medication management of elderly peritoneal dialysis (PD) patients with end-stage renal disease (ESRD) during COVID-19.
-
Clinical application of blood purification in polymyositis/dermatomyositis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-18 Jieting Jia, Defang Meng, Xuexiang Zhang, Nalin Lai, Beibei Zhou, Hua Wei, Xiaocong Li
We investigated the clinical efficacy and safety of blood purification technology in patients with polymyositis/dermatomyositis.
-
The superiority of bioimpedance vs. echocardiography and pitting edema in predicting automated office blood pressure in continuous ambulatory peritoneal dialysis patients Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-18 Mohammad Nekooeian, Jamshid Roozbeh, Shahrokh Ezzatzadegan Jahromi, Alireza Moaref, Fatemeh Masjedi
To achieve optimal blood pressure control in continuous ambulatory peritoneal dialysis (CAPD) patients, identifying methods of volume assessment with the strongest correlation with blood pressure is essential.
-
Monocyte-to-lymphocyte ratio and gastrointestinal disorder-related hospitalization in patients on maintenance hemodialysis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-13 Maolu Tian, Jing Yuan, Pinghong He, Fangfang Yu, Changzhu Long, Yan Zha
To explore the association between monocyte-to-lymphocyte ratio (MLR) and the risk of hospitalization due to gastrointestinal (GI) disorder in hemodialysis (HD) patients.
-
The effect of footbath applied to patients receiving hemodialysis treatment on comfort, fatigue, and dialysis symptoms: A randomized controlled study Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-10-01 Sevil Güler, Seda Şahan, Türkan Ülker, Murat Hayri Sipahioğlu
This study aimed to evaluate the effect of warm water footbaths on comfort, fatigue, and dialysis symptoms in patients undergoing hemodialysis.
-
Establishment of an adverse effect prevention protocol on plasma exchange using fresh frozen plasma prior to ABO-incompatible living donor kidney transplantation at our hospital Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-29 Akihito Tanaka, Yu Watanabe, Kazuhiro Furuhashi, Shoji Saito, Yoshinari Yasuda, Tomoki Kosugi, Yuta Sano, Masashi Kato, Shoichi Maruyama
Simple plasma exchange (PE) with fresh-frozen plasma replacement allows antibody removal for ABO-incompatible living donor kidney transplantation, but is associated with a high incidence of allergic reactions. We developed, implemented, and evaluated a protocol for safe preoperative PE.
-
Eligibility test for advanced chronic kidney disease: Revision and proposal Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-20 Rebeca García Agudo, Marina Méndez Molina, Sara Piqueras Sánchez, Antonio Tejera-Muñoz
Nowadays, chronic kidney disease (CKD) prevalence keeps increasing worldwide. The management of these patients usually requires renal replacement therapy (RRT). However, the complexity of patients' profiles comprises a great challenge to overcome. During the last decades, CKD units have been developed to offer multidisciplinary and coordinated attention to patients, helping in the decision-making of
-
Serum immunoglobulin G level reduction is a predictor of short-term improvement in patients with myasthenia gravis undergoing plasmapheresis Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-20 Shingo Konno, Toshiki Fujioka
The aim of the study was to investigate the serological factors in predicting symptom improvement in myasthenia gravis (MG) patients who underwent plasmapheresis (PP).
-
COVID-19 is more lethal in hemodialysis chronic kidney disease patients with low physical capacity Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-20 Rafael B. Orcy, Caroline C. Bluhm, Larissa R. Ribeiro, Priscila M. Sosa, Bianca D. Correa, Franklin C. Barcellos, Maristela Böhlke
The mortality rate in patients on maintenance hemodialysis (HD) is high and is associated with low functional capacity (FC). We analyzed the association of FC and COVID-19 lethality among HD patients.
-
Comparative outcomes of hemodialysis patients facing pre-Omicron and Omicron COVID-19 epidemics Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-19 Hiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, Taro Akihisa, Tomoko Kawanishi, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Tomohide Hanawa, Chise Sugita, Yoshiaki Kikkawa, Tetsuya Yamada, Sachiko Wakai
This study elucidates factors affecting the severity and mortality in pre-Omicron and Omicron strains of SARS-CoV-2 and vaccination impact.
-
Association between serum sodium and 28-day mortality in sepsis patients: A secondary data analysis from three large critical illness cohorts Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-13 Wei Li, Shuwen Li, Jia Yuan, Xianjun Chen, Qimin Chen, Chuan Xiao, Qing Li, Lu Li, Ying Liu, Juan He, Lu Chen, Feng Shen
The present study was designed to explore the association between serum sodium and mortality in patients with sepsis by using a large sample, multicenter MIMIC-IV database.
-
The addition of Cytosorb in patients on VA-ECMO improves urinary output and ICU survival Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-11 Daniel Lovrić, Marijan Pašalić, Stefan Križanac, Karla Kovačić, Boško Skorić, Hrvoje Jurin, Davor Miličić, Vedran Premužić
The aim of this study was to analyze the efficiency of CytoSorb adsorber in patients presenting with cardiogenic shock and treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO).
-
What is photopheresis? Role of extracorporeal photopheresis in the treatment of GvHD and its practice in Sweden Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-10 Yoshimi Fukumaki Karlsson, Gösta Berlin
CONFLICT OF INTEREST STATEMENT The authors have declared no conflicts of interest for this article.
-
The relationship between dietary inflammatory index and bone mineral density in CKD patients Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-09-10 Wenhui Wu, Xiurong Li, Jia Di, Hua Zhou, Hongyan Niu, Lu Chen, Qi Sha, Min Yang
Chronic systemic inflammation was proposed as a critical factor in the development of osteoporosis. We aim to investigate the effect of the DII on bone mineral density (BMD) in CKD patients.
-
Retrospective observational study of changes in serum cytokines and adiponectin with continuous plasma exchange with dialysis therapy for severe COVID-19 Ther. Apheresis Dial. (IF 1.9) Pub Date : 2023-08-31 Yuya Suzuki, Hajime Nakae, Kasumi Satoh, Nobuhisa Hirasawa, Komei Kameyama, Yasuhito Irie, Toshiharu Kitamura, Tasuku Nara, Kyohei Maeno, Kenji Yoshida, Manabu Okuyama
Coronavirus disease 2019 (COVID-19) is associated with a marked increase in the inflammatory cytokines, IL-6 and IL-18. Blood purification therapy aimed at controlling cytokines is one treatment option; however, evidence of its effectiveness is needed. Plasma exchange with dialysis (PED) is a blood purification method involving selective plasma exchange with dialysate flowing through the outer hollow